Yifeng Pharmary(SH:603939) Shang Hai Zheng Quan Bao·2025-07-30 17:43Core Viewpoint - The company has announced an extension of the completion date for its fundraising investment project, the "Yifeng Digital Platform Upgrade Project," from July 31, 2025, to December 31, 2025, without changing the project implementation subject, method, total investment amount, or purpose [2][5][6]. Fundraising Basic Information - The company issued 17,974,320 convertible bonds at a face value of RMB 100 each, raising a total of RMB 1,797.432 million. After deducting underwriting and sponsorship fees, the net amount raised was RMB 1,780.932 million [3][4]. Fundraising Usage Status - As of June 30, 2025, the company has invested RMB 73.621 million in the "Yifeng Digital Platform Upgrade Project," achieving an investment progress of 91.29% against a planned total investment of RMB 80.642 million [4]. Reasons for Project Delay - The delay in the "Digital Project" is due to the complexity of integrating multiple systems (product, logistics, finance, and human resources), which has led to challenges in platform integration and promotion. Additionally, some expenses related to personnel salaries and social insurance cannot be paid directly from the fundraising account, necessitating the use of self-owned funds initially [5][6]. Impact of Project Delay - The project delay is a prudent decision based on the actual implementation situation and will not adversely affect the company's normal operations or harm the interests of shareholders, particularly minority shareholders. The decision aligns with the company's long-term development plan [6][8]. Review Procedures and Opinions - The board of directors and the supervisory board approved the extension of the project completion date during meetings held on July 30, 2025. The supervisory board expressed agreement with the decision, confirming compliance with relevant laws and regulations [7][8][9].